Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 182,237 | 91,245 | 36,930 | 4,958 | 0 |
| Cost of Goods | 21,963 | 14,404 | 6,236 | 833 | N/A |
| Gross Profit | 160,274 | 76,841 | 30,694 | 4,125 | N/A |
| Operating Expenses | 465,274 | 406,022 | 472,915 | 186,848 | 130,437 |
| Operating Income | -304,037 | -328,777 | -441,985 | -181,890 | -130,437 |
| Interest Expense | 18,872 | 22,402 | 17,240 | 5,398 | 1,578 |
| Other Income | -33,001 | 2,090 | 10,104 | -16,493 | -103 |
| Pre-tax Income | -355,910 | -349,089 | -449,121 | -203,781 | -132,118 |
| Income Tax | 478 | -94 | -165,119 | -3,739 | N/A |
| Net Income Continuous | -356,388 | -348,995 | -284,002 | -200,042 | -132,118 |
| Net Income | $-356,388 | $-348,995 | $-284,002 | $-200,042 | $-132,118 |
| EPS Basic Total Ops | -1.48 | -1.88 | -1.85 | -1.49 | -1.20 |
| EPS Basic Continuous Ops | -1.48 | -1.88 | -1.85 | -1.49 | -1.20 |
| EPS Diluted Total Ops | -1.48 | -1.88 | -1.85 | -1.49 | -1.20 |
| EPS Diluted Continuous Ops | -1.48 | -1.88 | -1.85 | -1.49 | -1.20 |
| EPS Diluted Before Non-Recurring Items | -1.31 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-296,716 | $-313,585 | $-428,689 | $-175,959 | $-128,604 |